City

Nanjing (1)

Seoul (1)

Condition

DNA Damage Repair Deficiency (3)

Biliary Tract Cancer (1)

Chemotherapeutic Toxicity (1)

Chemotherapy Effect (1)

Hormone Sensitive Metastatic Prostate Cancer (1)

Oxidative Stress (1)

Sleep Quality (1)

Overall Status

Recruiting (2)

Unknown status (1)

Sign in for free

Phase

phase 2 (2)

phase 4 (1)

Sponsor

Asan Medical Center (1)

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)

University of British Columbia (1)

Collaborator

Intervention

docetaxel (1)

durvalumab (1)

melatonin (1)

olaparib (1)

placebo (1)

platinum-based drugs (1)

prednisolone acetate (1)

Study Documents

Intervention Type

drug (2)

dietary supplement (1)

other (1)

Funder Type

Other (3)

Study Type

Interventional (3)

dna damage repair deficiency

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency, Chemo Effect Trial in Nanjing (Docetaxel,

Recruiting

Hormone Sensitive Metastatic Prostate Cancer
+3 more

Docetaxel
+2 more

Nanjing, Jiangsu, China

Department of Urology, Drum Tower Hospital, Medical School of Na

Jul 13, 2022

Biliary Tract Cancer, DNA Damage Repair Deficiency Trial in Seoul (Durvalumab, Olaparib)

Recruiting

Biliary Tract Cancer
DNA Damage Repair Deficiency

Seoul, Korea, Republic of

Asan Medical Center

Apr 8, 2022

Sleep Quality, DNA Damage Repair Deficiency, Oxidative Stress Trial (Melatonin, Placebo)

Unknown status

Sleep Quality
+2 more

Melatonin
Placebo

(no location specified)

May 8, 2019